PLATO Trademark

Trademark Overview

On Friday, January 25, 2019, a trademark application was filed for PLATO with the United States Patent and Trademark Office. The USPTO has given the PLATO trademark a serial number of 88977547. The federal status of this trademark filing is REGISTERED as of Tuesday, June 9, 2020. This trademark is owned by AVROBIO, Inc.. The PLATO trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Platform as a service (PAAS) featuring gene therapy development platforms for treatments for rare and other diseases
plato

General Information

Serial Number88977547
Word MarkPLATO
Filing DateFriday, January 25, 2019
Status700 - REGISTERED
Status DateTuesday, June 9, 2020
Registration Number6076748
Registration DateTuesday, June 9, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 13, 2019

Trademark Statements

Goods and ServicesPlatform as a service (PAAS) featuring gene therapy development platforms for treatments for rare and other diseases

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, June 21, 2019
Primary Code042
First Use Anywhere DateSaturday, February 29, 2020
First Use In Commerce DateSaturday, February 29, 2020

Trademark Owner History

Party NameAVROBIO, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameAVROBIO, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameAVROBIO, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Friday, April 12, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, February 17, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 8, 2019ASSIGNED TO EXAMINER
Friday, April 12, 2019NON-FINAL ACTION WRITTEN
Friday, April 12, 2019NON-FINAL ACTION E-MAILED
Thursday, June 20, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 20, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 21, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 27, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 11, 2019ASSIGNED TO LIE
Wednesday, July 24, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 13, 2019PUBLISHED FOR OPPOSITION
Tuesday, August 13, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 8, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 31, 2020TEAS STATEMENT OF USE RECEIVED
Tuesday, March 31, 2020TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, March 31, 2020DIVISIONAL REQUEST RECEIVED
Tuesday, March 31, 2020USE AMENDMENT FILED
Tuesday, April 21, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, April 21, 2020DIVISIONAL PROCESSING COMPLETE
Tuesday, April 21, 2020STATEMENT OF USE PROCESSING COMPLETE
Thursday, May 7, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, May 8, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 9, 2020REGISTERED-PRINCIPAL REGISTER
Monday, June 9, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

plato treatments platforms rare other diseases development therapy service paas featuring